ARE THYMUS-DERIVED LYMPHOCYTES (T-CELLS) DEFECTIVE IN THE NASOPHARYNGEAL AND PALATINE TONSILS OF CHILDREN

被引:22
作者
BERNSTEIN, JM
RICH, GA
ODZIEMIEC, C
BALLOW, M
机构
[1] SUNY BUFFALO,DEPT OTOLARYNGOL,BUFFALO,NY 14260
[2] SUNY BUFFALO,DEPT PEDIAT,BUFFALO,NY 14260
[3] CHILDRENS HOSP BUFFALO,DIV INFECT DIS,BUFFALO,NY
[4] CHILDRENS HOSP BUFFALO,DIV ALLERGY & CLIN IMMUNOL,BUFFALO,NY
关键词
D O I
10.1177/019459989310900410
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The present study was conducted to evaluate the response of adenoidal T cells and B cells in the production of immunoglobulins. There appears to be a consistent inability of adenoidal T cells to turn on B cells to mature into immunoglobulin-secreting plasma cells. This phenomenon did not appear to be due to suppressor activity of adenoidal T cells because T cells from other sources appeared to effectively result in adenoidal B cell maturation, even in the presence of adenoidal T cells. Both tonsils and adenoids appear to have defective IL-2 production, in response to both mitogens and specific antigens. It is hypothesized that a cytokine(s) may be released in adenoids that downregulate IL-2 production and result in immune suppression in the adenoids of children with recurrent otitis media and chronic sinusitis.
引用
收藏
页码:693 / 700
页数:8
相关论文
共 17 条
[11]   EFFICACY OF ADENOIDECTOMY FOR RECURRENT OTITIS-MEDIA IN CHILDREN PREVIOUSLY TREATED WITH TYMPANOSTOMY-TUBE PLACEMENT - RESULTS OF PARALLEL RANDOMIZED AND NONRANDOMIZED TRIALS [J].
PARADISE, JL ;
BLUESTONE, CD ;
ROGERS, KD ;
TAYLOR, FH ;
COLBORN, DK ;
BACHMAN, RZ ;
BERNARD, BS ;
SCHWARZBACH, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (15) :2066-2073
[12]  
Pross H F, 1974, Adv Immunol, V18, P133, DOI 10.1016/S0065-2776(08)60309-0
[13]   INTERLEUKIN-2 - THE MOLECULE AND ITS FUNCTION [J].
ROBB, RJ .
IMMUNOLOGY TODAY, 1984, 5 (07) :203-209
[14]  
SHIMAMURA K, 1990, ARCH OTOLARYNGOL, V116, P1143
[15]  
STIEHM ER, 1979, PEDIATRICS, V64, P814
[16]  
SUGIYAMA M, 1983, INT J PEDIATR OTORHI, V6, P195
[17]  
VANDEPLASSCHEBOERS EM, 1988, CLIN EXP IMMUNOL, V73, P348